Lidocaine for pain and discomfort relief during nasogastric tube insertion: A systematic review.
4 affiliations
- 1Scientific Office, Deventer Hospital, Nico Bolkesteinlaan 75, Deventer, 7416 SE, The Netherlands.
- 2Centre for Abdominal and Pelvine Care, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, 6525 GA, The Netherlands.
- 3Department of Surgery, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, 6525 GA, The Netherlands.
- 4Oncologic Centre, Deventer Hospital, Nico Bolkesteinlaan 75, Deventer, 7416 SE, The Netherlands.
Abstract
Background
Nasogastric tube (NGT) insertion is a common procedure in hospitalized adults, associated with pain and discomfort. Lidocaine has been studied to reduce procedural pain, but evidence on the most effective, clinically feasible approach remains limited.Objective
This review aimed to systematically review and synthesise evidence on the effectiveness and safety of topical anaesthetics or lubricants for reducing pain and discomfort during NGT insertion in adults.Method
A systematic search was conducted in MEDLINE, Cochrane Database of Systematic Reviews, CENTRAL, and CINAHL from inception to October 28, 2025. Randomized controlled trials (RCTs) in adults were eligible if they assessed non-nebulised topical anaesthetics or lubricants and reported pain, discomfort, procedure-related outcomes, or complications. Screening, data extraction, and quality assessment using the 13-item JBI Critical Appraisal Checklist for RCTs were performed independently by two reviewers. Findings were synthesised descriptively using a best-evidence approach.Results
Of 390 unique records, five RCTs were included. Studies investigated lidocaine in various formulations and administration routes, including spray, drops, gel, and atomised lidocaine, compared with placebo. Despite heterogeneity in study characteristics, all studies reported reductions in pain or discomfort scores with lidocaine. Best-evidence synthesis showed strong evidence for pain reduction and moderate evidence for reductions in discomfort and cough. Evidence for other procedure-related outcomes was insufficient.Conclusion
Topical lidocaine during NGT insertion in adults appears to reduce pain and is well tolerated. However, heterogeneity and limited data preclude strong recommendations. Further high-quality trials are warranted to identify optimal formulation, dosage, and administration route for routine practice.Registration
The review was registered in the international prospective register of systematic reviews (http://www.crd.york.ac.uk/PROSPERO/), registration number: CRD420251177888.
Related
- Perioperative intravenous lidocaine for the prevention of chronic postsurgical pain: a systematic review and meta-analysis of randomized controlled trials
- Gut relief revisited: plecanatide in chronic idiopathic constipation and irritable bowel syndrome with constipation — a systematic review and meta-analysis with GRADE assessment
- Exploratory Reanalysis of the Lithuanian OHIP-14 in Older Adults: Preliminary Evidence for an Oral Discomfort Structure
- Characterizing the mechanisms that determine the strength of the subjectively perceived discomfort during transcranial magnetic stimulation
- OP–122 Effect of lidocaine-prilocaine cream and cold application on chest tube removal in children
BibTeX
@article{kessel2026lidocaine,
title = {{Lidocaine for pain and discomfort relief during nasogastric tube insertion: A systematic review.}},
author = {Femke van Kessel and Harm H J van Noort and Minke Reimink and Kim Kamphorst},
journal = {International journal of nursing studies advances},
year = {2026},
month = oct,
doi = {10.1016/j.ijnsa.2026.100710},
url = {https://europepmc.org/article/MED/42927150},
note = {CC BY},
}
RIS
TY - JOUR
TI - Lidocaine for pain and discomfort relief during nasogastric tube insertion: A systematic review.
AU - Femke van Kessel
AU - Harm H J van Noort
AU - Minke Reimink
AU - Kim Kamphorst
PY - 2026
DA - 2026/10/14
JO - International journal of nursing studies advances
DO - 10.1016/j.ijnsa.2026.100710
UR - https://europepmc.org/article/MED/42927150
AB - Background Nasogastric tube (NGT) insertion is a common procedure in hospitalized adults, associated with pain and discomfort. Lidocaine has been studied to reduce procedural pain, but evidence on the most effective, clinically feasible approach remains limited.Objective This review aimed to systematically review and synthesise evidence on the effectiveness and safety of topical anaesthetics or lubricants for reducing pain and discomfort during NGT insertion in adults.Method A systematic search was conducted in MEDLINE, Cochrane Database of Systematic Reviews, CENTRAL, and CINAHL from inception to October 28, 2025. Randomized controlled trials (RCTs) in adults were eligible if they assessed non-nebulised topical anaesthetics or lubricants and reported pain, discomfort, procedure-related outcomes, or complications. Screening, data extraction, and quality assessment using the 13-item JBI Critical Appraisal Checklist for RCTs were performed independently by two reviewers. Findings were synthesised descriptively using a best-evidence approach.Results Of 390 unique records, five RCTs were included. Studies investigated lidocaine in various formulations and administration routes, including spray, drops, gel, and atomised lidocaine, compared with placebo. Despite heterogeneity in study characteristics, all studies reported reductions in pain or discomfort scores with lidocaine. Best-evidence synthesis showed strong evidence for pain reduction and moderate evidence for reductions in discomfort and cough. Evidence for other procedure-related outcomes was insufficient.Conclusion Topical lidocaine during NGT insertion in adults appears to reduce pain and is well tolerated. However, heterogeneity and limited data preclude strong recommendations. Further high-quality trials are warranted to identify optimal formulation, dosage, and administration route for routine practice.Registration The review was registered in the international prospective register of systematic reviews (http://www.crd.york.ac.uk/PROSPERO/), registration number: CRD420251177888.
SN - 2666-142X
ER -